Subclassification of preproliferative diabetic retinopathy and glycemic control: Relationship between mean hemoglobin A(1C) value and development of proliferative diabetic retinopathy

Citation
Y. Sato et al., Subclassification of preproliferative diabetic retinopathy and glycemic control: Relationship between mean hemoglobin A(1C) value and development of proliferative diabetic retinopathy, JPN J OPHTH, 45(5), 2001, pp. 523-527
Citations number
8
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Optalmology
Journal title
JAPANESE JOURNAL OF OPHTHALMOLOGY
ISSN journal
0021-5155 → ACNP
Volume
45
Issue
5
Year of publication
2001
Pages
523 - 527
Database
ISI
SICI code
0021-5155(200109/10)45:5<523:SOPDRA>2.0.ZU;2-I
Abstract
Purpose: We evaluated the relationship between long-term glycemic control a nd the proportion of patients developing proliferative diabetic retinopathy (PDR) among cases with mild type preproliferative diabetic retinopathy (PP DR). Methods: The relationship was evaluated between the mean hemoglobin A(1C) ( HbA(1C)) value during a period of at least 2 years and the proportion of pa tients developing PDR among cases with mild type PPDR, based on our previou sly proposed subclassification. Results: During follow-up, 27% of the total PPDR cases developed PDR. The m ean HbA(1C) value in those patients who had developed PDR was 9.4% and was significantly higher than the 7.6% in those who had not developed PDR. The proportion developing PDR was 48% of the cases with a mean HbA(1C) value of 8.6% or more. By comparison, the proportion developing PDR was 8% among th ose with a mean HbA(1C) value below 8.6%. The proportion developing PDR was estimated to approximately double with each 1% increase in the mean HbA(1C ) value. The cumulative occurrence rates of PDR at 2, 5, and 10 years were estimated to be 5%, 28%, and 60% in cases with a mean HbA(1C) value of 8.6% or more, and 0%, 7%, and 14% in those with a mean HbA(1C) value below 8.6% , respectively. Conclusion: Stricter systemic and ophthalmological control is indicated for cases with a mean HbA(1C) value exceeding 8.6%. Jpn J Ophthalmol 2001;45:5 23-527 (C) 2001 Japanese Ophthalmological Society.